Insider sale
ARROWHEAD PHARMACEUTICALS, INC.
$1.39M
20K shares
What this filing means
HAMILTON JAMES C plans to sell 20K shares of ARROWHEAD PHARMACEUTICALS, INC. valued at approximately $1.39M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/23/2026ACC: 0001628280-26-026884
Other
Since Oct 2020
20K
Shares to sell
$1.39M
Approx. market value
10K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months4
Compensation
Compensation
1/4/2026
2.12KCompensation
Compensation
1/4/2026
5.71KCompensation
Compensation
1/4/2026
1.63KCompensation
Compensation
1/4/2026
542.00Total acquired10K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/4/2026 | Compensation Compensation | 2.12K | — |
1/4/2026 | Compensation Compensation | 5.71K | — |
1/4/2026 | Compensation Compensation | 1.63K | — |
1/4/2026 | Compensation Compensation | 542.00 | — |
| Total | 10K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
10K
Market value
$641.9K
3/5/2026
Planned — Approximate Date
NasdaqPlanned
Units to sell
10K
Market value
$750.0K
4/23/2026
Total
Units
20K
Value
$1.39M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/5/2026 | 10K | $641.9K | — | Completed |
| Planned — Approximate Date | ||||
4/23/2026 | 10K | $750.0K | Nasdaq | Planned |
| Total | 20K | $1.39M | ||